Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

CABA – cabaletta bio, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CABA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/5
09:27 am
caba
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Medium Report
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Report
2/5
08:00 am
caba
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Medium Report
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Report
1/30
07:12 pm
caba
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
Medium Report
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
Report
1/27
11:07 am
caba
Cabaletta Bio: Do You Buy With The Insiders? [Seeking Alpha]
Low Report
Cabaletta Bio: Do You Buy With The Insiders? [Seeking Alpha]
Report
1/12
08:27 am
caba
Cabaletta Bio Announces 2026 Strategic Priorities [Yahoo! Finance]
Medium Report
Cabaletta Bio Announces 2026 Strategic Priorities [Yahoo! Finance]
Report
1/12
08:00 am
caba
Cabaletta Bio Announces 2026 Strategic Priorities
Medium Report
Cabaletta Bio Announces 2026 Strategic Priorities
Report
1/12
07:30 am
caba
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
Medium Report
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
Report
12/15
07:15 am
caba
Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? [Yahoo! Finance]
Low Report
Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? [Yahoo! Finance]
Report
11/10
07:59 am
caba
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium Report
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Report
11/10
07:55 am
caba
Cabaletta Bio GAAP EPS of -$0.44 beats by $0.04 [Seeking Alpha]
Medium Report
Cabaletta Bio GAAP EPS of -$0.44 beats by $0.04 [Seeking Alpha]
Report
11/10
07:30 am
caba
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium Report
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0